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Abstract
Background: The turnover of acetylcholine receptors at the neuromuscular junction is regulated in an activity-dependent
manner. Upon denervation and under various other pathological conditions, receptor half-life is decreased.
Methodology/Principal Findings: We demonstrate a novel approach to follow the kinetics of acetylcholine receptor
lifetimes upon pulse labeling of mouse muscles with 125I-a-bungarotoxin in vivo. In contrast to previous assays where
residual activity was measured ex vivo, in our setup the same animals are used throughout the whole measurement period,
thereby permitting a dramatic reduction of animal numbers at increased data quality. We identified three stability levels of
acetylcholine receptors depending on the presence or absence of innervation: one pool of receptors with a long half-life of
,13 days, a second with an intermediate half-life of ,8 days, and a third with a short half-life of ,1 day. Data were highly
reproducible from animal to animal and followed simple exponential terms. The principal outcomes of these measurements
were reproduced by an optical pulse-labeling assay introduced recently.
Conclusions/Significance: A novel assay to determine kinetics of acetylcholine receptor turnover with small animal
numbers is presented. Our data show that nerve activity acts on muscle acetylcholine receptor stability by at least two
different means, one shifting receptor lifetime from short to intermediate and another, which further increases receptor
stability to a long lifetime. We hypothesize on possible molecular mechanisms.
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Introduction
Muscle contraction in vertebrates is mediated by the activation
of nicotinic acetylcholine receptors (AChRs) at the nerve-muscle
synapse, the neuromuscular junction (NMJ). NMJs exhibit a
peculiar gross-morphology and ultrastructure [1,2,3]. En face view
of NMJs reveals elaborate structures, which often assume a
roundish, circular to ellipsoid shape with diameters of roughly 20–
50 mm. Internally, these shapes consist of AChR-rich band-like
arbors, which have a width of about 1–3 mm and are usually all
connected with each other, forming what is often called a
‘‘pretzel’’ appearance. Notably, pre- and postsynaptic arbors of
the pretzel normally overlap perfectly, indicating an intense and
fine-tuned crosstalk that mediates proper positioning of compo-
nents on both sides. Postsynaptically each arbor exhibits a rich
membrane topology with secondary clefts branching off from the
primary cleft, which itself connects to the smooth presynaptic
membrane. The crests of folds created by the secondary clefts are
covered with roughly 10,000 AChRs per mm2. Another hallmark
of the postsynaptic apparatus is the presence of some 4–7
subsynaptic or fundamental nuclei, which lie directly beneath
the postsynaptic membrane and which, in the muscular syncytium,
specialize on the production of synapse-specific transcripts, such as
AChR, acetylcholine esterase or rapsyn [4]. While NMJs are built
in the unborn animal and are then kept in place for very long time
periods, AChRs have lifetimes of only several days [1].
In order to maintain the high density of AChRs at the
junctional crests and to permit the perfect matching to the
presynapse over time, AChR transport mechanisms are required
[1]. Exo- and endocytic processes mediate delivery of newly
formed and retrieval of old/excess receptors, respectively. In
addition, recycling of AChRs commences in the first postnatal
days in mouse and adapts AChR density in the postsynapse to
strain [5,6,7]. Furthermore, this process may be necessary for
restructuring purposes. AChR recycling is linked to metabolic
stabilization of AChRs, which in turn is highly dependent on the
activity of motor nerve and muscle [5,6,8,9,10,11]. While in
healthy innervated mouse muscles receptor half-life is ,10–13
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days, denervation reduces the receptor half-life to ,1 day [8,12].
Since muscle stimulation [13] as well as pharmacologically
induced increase in cAMP levels [14,15] recovers AChRs in
denervated muscles from fast turnover, muscle-dependent as well
as nerve-dependent processes seem to modulate receptor stability.
At the postsynaptic side myosin Va forms a complex with recycling
AChRs and PKA RIa and the cooperative action of this complex
is important for proper recycling of AChRs [9,10,11,16].
To address AChR turnover kinetics, different approaches have
been adopted so far. Harnessing the quasi-irreversible binding of
the snake venom, a-bungarotoxin (BGT) [17] and the possibility
to link BGT to biotin, fluorescent dyes or radioisotopes,
microscopic and scintillation counting-based methods were
established. While microscopic approaches have mainly delivered
important insights into the spatial and structure-function aspects
of AChR turnover [5,6,7,8,9,10,16,18], radioactive assays using
125I-BGT have revealed the basic quantitative insights into the
time constants underlying AChR turnover [12]. Albeit being the
method of choice for determining precise AChR kinetics, a
widespread use of the radiolabeling technique also for genetically
manipulated mouse strains might have been hampered by the
large quantities of animals and radioisotope necessary to achieve
reliable statistics. We here introduce a novel 125I-BGT-based
assay to determine AChR turnover, which allows reducing the
number of animals and the starting material by a factor of at least
ten without compromising data quality. Furthermore, we describe
the presence of three levels of AChR stabilization and discuss
possible mechanisms underlying the formation of these receptor
pools.
Results
A portable detector system for the study of AChR lifetime
kinetics
In this study we established an assay to follow lifetime kinetics
of AChRs using in vivo pulse labeling of AChRs with 125I-BGT
and subsequent repetitive measurement of 125I emission with a
portable Germanium semiconductor counter. 125I-BGT was
injected once into the tibialis anterior (TA) muscles of
anaesthetized mice, which were then mounted onto a lead
support (Fig. 1A). To measure 125I emission only from the
injected muscle and not from the whole animal, a lead shield with
a circular fenestration at the height of the mounted TA muscle
was placed between mouse and detector (Fig. 1A–B). In most
cases, both legs were injected and during denervation experi-
ments (see below) one side served as untreated control. For each
leg, a measurement period of five minutes was sufficient. By using
such short detection windows together with volatile isoflurane
anesthesia (Fig. 1A) the entire measurement series could be
performed using identical animals. Fig. 1C shows a typical
irradiation spectrum as detected by the sensor and Fig. S1 depicts
the precise setup of the detector. Measurement of a standard 125I-
BGT-injection dose kept in the test tube as a reference revealed a
t1/2 of 58.7 days for
125I (Fig. 1D). This was very similar to the
theoretical t1/2 of this nuclide of 59.4 days (Decay Data
Evaluation Project, http://www.nucleide.org/DDEP_WG/
DDEPdata.htm), and shows that even much longer t1/2 than
the ones expected for AChRs (about 10 days) could be measured
reliably using this approach.
Based on these findings, we started first in vivo experiments to
determine the distribution of intramuscularly injected 125I-BGT
within the body. Repetitive measurements in the first minutes
after injection showed a rapid loss of radioactive signal from the
injected muscles (Fig. 2A shows a representative trace). This
suggested that most of the injected 125I-BGT did not bind to
AChRs but quickly left the TA muscle, presumably through the
blood stream or the lymphatic system. Due to this process one
day after 125I-BGT-injection about 90% of the initially measured
radioactivity was lost from the injected muscles. From that time
point onwards, the decline of 125I-BGT-emission was much
slower and roughly followed a single exponential term in
innervated mice (Fig. 2A, for more detailed analyses, see Fig. 3)
with a 125I-half-life-corrected decay time of about 11 days
(Fig. 2A). These values are very similar to previously described
results [12]. To better understand the destination of the residual
125I-BGT, we measured the amounts of 125I after a 25 days long
experiment in mouse and litter. Cage litter was sampled on days
1, 7 and 25 after pulse labeling to investigate the kinetic
properties of probe expulsion. As shown in Table 1, about 60% of
the injected 125I was excreted during the first day after injection.
In the following period, the amount of radioactivity present in the
litter samples progressively decreased, adding up to a total of 70%
of the total radioactivity in the litter. Five percent of the total
activity was found in the animal on day 25 after pulse labeling,
leaving a loss of 25%. We speculate that most of this activity was
present in feces and urine released during the measurement
periods, in particular, during the first measurement and during
the following wake-up period. As to the activity residing in the
animal over the entire experimental period, we expected most of
it to enrich in other skeletal muscles. To investigate this, we
analyzed the forelegs of hindlimb-injected mice. Interestingly,
about 1% of the total injected 125I-BGT was detected there and
exhibited a very similar, roughly single-exponential decay as that
in the TA muscle (Fig. 2B). This suggests that 125I-BGT released
during the first minutes after injection is accumulating in other
muscles, where it binds to AChRs. The similarity in the decay
times of both observed muscles indicates that the amount of 125I-
BGT injected into the TA muscle did not significantly interfere
with AChR turnover at the site of injection.
Dependence of AChR lifetime on different muscle-
activity stimuli is revealed by two independent
approaches
Next, we injected left and right TA muscles of anesthetized mice
with 125I-BGT and simultaneously denervated the left legs by
cutting the sciatic nerves on this side (acutely denervated in Fig. 3).
Contralateral muscles were kept innervated. In another set of
experiments, one side was denervated five days prior to pulse
labeling (long-term denervated in Fig. 3) and the contralateral
muscle was again kept innervated as control. Since all control
values were very similar, they were pooled in the graphs depicted
in Fig. 3. Subsequent repetitive monitoring of 125I emission over a
time period of four weeks showed interesting features. First, data
sets obtained under all three experimental conditions could be
nicely fitted with double-exponential terms (Fig. 3A), indicating the
presence of two distinct AChR populations in each preparation.
However, while two AChR populations were found in all cases,
population sizes and their durations were dependent on the
specific condition. An overview on these values is given in Table 2.
We found that a fast decaying component with a t1/2 of 1.160.4
days (mean 6 SEM) was present in all three preparations. This is
easily visible upon comparing Fig. 3A–D, showing that the
apparent size of this compartment was dependent on the starting
point of normalization. Indeed, upon normalization of the data set
to day seven after pulse labeling (Fig. 3D) the fast compartment
was undetectable in innervated and acutely denervated muscles.
Furthermore, while this population was largest in the long-term
denervated muscles it was present at similar amounts in innervated
Three AChR Stability Levels
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Figure 1. A novel setup allows monitoring of AChR turnover in
live mice. A: Photograph of the setup showing the anaesthetized
125I-BGT-injected mouse mounted onto the lead support shielding left
from right body half. A lead shield with a 16.5 mm wide perforation at
the height of the TA muscle limits the detected 125I-emission to that of
the lower hindlimb. B: Schematic drawing illustrating the emission path
from injected lower hindlimb to the Germanium semiconductor sensor.
C: Typical emission spectrum as detected upon injection of 125I-BGT.
The integrals below peak 1 were used for quantification of AChR
turnover. D: Decay of a non-injected 125I-BGT-standard. Dots, measured
values; dotted line, exponential fit based on measured values;
continuous line, theoretical decay curve of 125I.
doi:10.1371/journal.pone.0020524.g001
Figure 2. Most intramuscularly injected 125I-activity rapidly
becomes available systemically. 125I-BGT was injected into TA
muscles of mice. 125I-emission was repetitively measured immediately
after injection (time point 0) and subsequently at time points as
indicated. A: Residual 125I-BGT-emission in the injected hindlimb as a
function of time after pulse labeling. Dots, measured values; continuous
line, two-term exponential fit; dotted lines, extrapolations for the two
different exponential terms. This data series had four measurements
shortly after 125I-BGT injection. A t1/2 of 49 min was calculated for the
expulsion of 125I-activity from the injected TA muscle during the first
day after pulse labeling. B: 125I-BGT-emission in the injected hindlimb
(black dots) and the ispilateral foreleg (white dots) normalized to the
value measured immeditaley after pulse labeling in the injected
hindlimb as a function of time after pulse labeling. Continuous lines
show a two-term exponential fit and a ‘Bateman’ function for the
hindlimb and the foreleg, respectively. The latter describes the result of
the two exponential processes, (i) infiltration of 125I-BGT upon release
from the hindlimb and (ii) subsequent exponential decay with the same
half-life as in the hindlimb. The dotted line indicates the extrapolation
for the fit of the expulsion component. Note, that systemically available
125I-BGT accumulates in foreleg muscles and shows a similar decay as in
the injected hindlimb muscle.
doi:10.1371/journal.pone.0020524.g002
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and acutely denervated specimens. When concentrating on the last
three weeks of data sampling (see e.g. Fig. 3D), it was evident that
two different slowly decaying AChR populations existed. AChRs
from innervated muscles were more stable than those from
denervated ones. This was reflected by half-lives of 13.1 days and
8.1 days for innervated and denervated muscles, respectively. The
slight offset in the long-term denervated curve in Fig. 3D is due to
a little remnant of the fast component in these muscles. Altogether,
these data show the presence of three different types of receptor
stability, i.e. high, intermediate and low.
To further consolidate these findings, we used a recently
described in vivo imaging approach [9,10], where two distinct
AChR pools are differentially color-labeled. Therefore, in a first
round, mice were unilaterally denervated (acutely denervated) by
cutting the left sciatic nerve and the preexisting AChRs were
simultaneously marked on both legs with BGT coupled to
AlexaFluor 647 (BGT-AF647). Ten days later, the same muscles
were again injected with BGT, which was now labeled with
AF555. Subsequent in vivo imaging revealed the relative
distributions of AF647 (old receptors) and AF555 signal intensities
(new receptors) (Fig. 3E). Quantitative analysis of the fraction of
pixels with dominant AF555 signals per NMJ showed a significant
ratio increase in denervated muscles, indicating a shorter AChR
lifetime under this condition (Fig. 3F). In a second series of
experiments, nerves were cut five days before the injection of
BGT-AF647 (long-term denervated). Again ten days later, NMJs
were imaged after acute labeling of new AChRs with BGT-
AF555 (Fig. 3E). This showed an even higher increase of the
AF555/AF647 ratio (Fig. 3F), suggesting that old receptors
labeled in a denervated muscle underwent a further reduction of
their lifetime.
Discussion
The earliest attempts to determine the activity-dependent
lifetime of synaptic AChRs date back to the 1970’s [19] and
scintillation counter-based assays using 125I-BGT as a labeling
probe were optimized and widely used up to the 1990’s [12,20]. At
this time the principal role of nerve activity on metabolic
stabilization of AChRs was completely established. However, the
rather recent finding of considerable functional analogies between
the NMJ and central synapses [11,21], including activity-
dependent neurotransmitter receptor recycling [5,6,7,8,16], the
role of receptor-associated proteins [22], and the role of PKA-
dependent signaling and class V myosins for regulating receptor
turnover [9,10,11], have triggered novel interest in this branch of
NMJ research. Furthermore, the demonstration of the beneficial
effect of long-term caloric restriction on NMJ structure preserva-
tion in aged mice [23] are likely to place the NMJ center stage
between body metabolism and muscle performance in aging and
metabolic diseases. Based on these aspects and the ongoing
production of relevant genetic mouse models in these areas of
research there is need for efficient tools to study AChR turnover as
a major diagnostic feature of NMJ integrity and NMJ activity. The
method presented here of quantitatively determining AChR
turnover shares the use of 125I-BGT with previous assays.
However, a special Germanium semiconductor sensor in this
study allows measuring AChR decay kinetics in situ. Therefore
single mice can be used for entire measurement series without
compromising data quality. This reduces the amount of animals
needed to acquire reliable data by a factor of 10–15 compared to
previous settings. This is particularly relevant for the investigation
of rare or weakly reproducing strains.
Similar to previous reports [14,15,24] our studies using
innervated and denervated conditions have revealed three
different receptor lifetimes with t1/2 values of 1.1 day, 8.1 days
and 13.1 days. However, in contrast to previous measurements the
new in vivo assay permits the acquisition of complete kinetics for
individual mice, thereby reducing the uncertainty of biological
variability. The presence of all three populations was highly
reproducible and the lifetime values of the different populations
were very similar to previous reports [8,14,15,24]. Notably, the
short-lived population was found to be present under all
experimental conditions, i.e. also under innervation. Very likely,
these short-lived receptors represent extrasynaptic AChRs, which
are formed at low density all along the muscle fiber. An alternative
explanation would be that transient blockage of synapse activity by
bungarotoxin binding to AChRs led to increased receptor
turnover [8]. However, to achieve such inactivation more than
70% of receptors need to be occupied by bungarotoxin [25]. We
estimate to label only about 40% of AChRs in the current
approach, a value that was also used by others as a non-blocking
Table 1. Most 125I activity is excreted by the animal during
the first day after pulse labeling.
Sample
125I activity
(% of total injected activity*)
litter day 1 after pulse labeling 60
litter days 2–7 after pulse labeling 9
litter days 8–25 after pulse labeling 1
mouse 5
loss 25
TA muscles of an anaesthetized mouse were injected with 125I-BGT on day zero.
The cage litter was sampled on days 1, 7, and 25 after pulse labeling. Litter
samples and the mouse after sacrificing on day 25 after pulse labeling were
measured for 125I activity. Data are from a representative experiment. *All values
were corrected for their radioactive decay.
doi:10.1371/journal.pone.0020524.t001
Figure 3. The novel approach reveals three levels of metabolic stabilization of AChRs. A–D: Muscles were either left innervated
(innervated) or the were denervated immediatedly prior to (acutely denervated) or five days before pulse labeling with 125I-BGT (long-term
denervated). Time point of pulse labeling is t0. Graphs in A–D show the residual 125I-emission in the injected hindlimbs as a function of time after
pulse labeling. Dots, measured values (mean 6 SD; n-values: control n = 10, acutely denervated n= 5, long-term denervated n= 4); lines, two-term
exponential fits. Data are normalized to the mean values measured on day 1 (A), day 2 (B), day 3 (C) or day 7 (D) to highlight the progressive loss of
the short-lived AChR population with increasing time after pulse labeling. During the first week of chase muscles were measured at intervals of
24 hours. Already at the day 1 measurement less than 1025% of unbound 125I-BGT was left. E–F: Muscles were innervated or denervated as in A–D,
but instead of 125I-BGT BGT-AF647 was injected at t0. Ten days later BGT-AF555 was injected to label newly formed AChRs. Subsequently, in vivo
imaging was performed and synapses were automatically segmented and analyzed. E: Representative maximum z-projections of microscopic fields
showing signals of BGT-AF647 (‘old receptors’), BGT-AF555 (‘new receptors’) and overlay of both (‘old receptors in green’, ‘new receptors’ in red) on
day ten after labeling with BGT-AF647. Scale bar, 50 mm. F: Quantification of the fraction of pixels with dominant ‘new receptor’ label of the entire
NMJ pixels as a function of innervation/denervation status of the analyzed muscle. Mean 6 SEM (n-values: control n = 3, acutely denervated n= 4,
long-term denervated n= 3). * P,0.05 according to Welch test.
doi:10.1371/journal.pone.0020524.g003
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dose of bungarotoxin [8]. We do therefore not expect any effect of
the labeling procedure on receptor stability. This is supported by
the finding, that forelegs, which took up small amounts of the
bungarotoxin injected into the hindlimbs, showed similar AChR
lifetime kinetics (Fig. 2B) as well as by the observation that the
animals did not drag their feet upon injection. Nonetheless, the
fact, that we can not distinguish clearly between those different
localizations of AChRs is an obvious caveat of the current
approach. The size of the short-lived pool was similar in
innervated and acutely denervated muscles, confirming previous
studies which showed that destabilization of AChRs to the short-
lived kinetics of about one day is not an immediate process, but
involves incorporation of novel receptors [15,16]. This was further
corroborated by our long-term denervation experiment: there,
most AChRs were replaced by short-lived receptors. In summary,
these data corroborate earlier studies in that nerve-activity-
dependent signals are necessary to slow down AChR turnover
beyond the basal, 1-day half-life.
Soon after denervation transcription is switched from adult
(a2bed) to embryonic-type AChRs (a2bcd) [16]. Since a similar
switch, just from embryonic to adult AChRs, occurs in the early
postnatal phase [26], when receptor stabilization is taking place
in mice [16], it is intriguing to speculate that the c-to-e switch
could be the molecular mechanism underlying the changes in
activity-dependent AChR lifetimes. However, a recent study has
shown that perinatal AChR stabilization is not depending on e-
subunits [7] rendering unlikely that a transcription-dependent
mechanism is adopted upon denervation. Thus, other processes
like competition for space at the synapse [7] or posttranslational
modifications of AChRs or of accompanying molecules can be
envisaged to account for shifting the short to a longer half-life. In
the following discussion we call this unknown mechanism ‘‘signal
1’’ (S1, Fig. 4).
The comparison of denervated and innervated muscles
revealed a further step of AChR stabilization shifting the t1/2 of
the long-lived AChR population from 8 days in the denervated to
13 days in the innervated condition. Similar observations were
made earlier [24,27]. This implies the existence of a second signal
(S2, see Fig. 4A), which is to be present between days two and
eight after receptor incorporation. Thus, a two-step activity-
dependent signaling appears to be necessary to fully stabilize
AChRs (Fig. 4A). Previous studies from different labs have shown
that AChR distribution within NMJs is unequal, showing higher
densities at the borders than at the center of synapses [1].
Furthermore, also the addition of newly synthesized AChRs
occurs in an asymmetric fashion [9,16,18]: Being added at the
periphery of the synapse, they appear to travel towards the center
of NMJs with increasing lifetime (Fig. 4B). Electron microscopy of
individual arbors of the NMJ gross morphology (Fig. 4C) shows
that subsynaptic nuclei, which are specialized in the production of
synapse-specific transcripts, are in close proximity to the folded
postsynaptic apparatus. The secretory pathway, through which
AChRs have to funnel to reach the synaptic membrane, is weakly
developed around subsynaptic nuclei, suggesting a limited
transcriptional activity of transmembrane proteins. Notably,
Golgi apparatuses are often found on one end of synaptic
branches as shown in Fig. 4C (see label ‘‘G’’) adding
morphological support to the observation of asymmetric receptor
incorporation. However, if AChRs are not added evenly to the
synapse, they must be distributed subsequently by other
mechanisms. We speculate that this is achieved either by directed
lateral transport along the plasma membrane or by directed
recycling processes. In both cases the net flux of AChRs would be
from the lateral side of incorporation to the central region
(Fig. 4D). Overlaying AChR lifetimes and the hypothetical
process of AChR movement within the postsynaptic apparatus
during this lifetime, we come up with a concluding hypothesis.
According to this hypothesis the two steps of nerve-dependent
receptor stabilization are executed at different sites of the NMJ.
We think that the first signal, S1, is likely to reach the receptors at
or close to the site of receptor incorporation into the synapse, i.e.
at the rim of the NMJ (Fig. 4D). Subsequent directed movement
of the AChRs allows the receptors to reach the site of the
secondary stabilizing signal, S2, which would then be located
more towards the center of the synapse (Fig. 4D).
Many aspects of this hypothetical model still need to be solved.
These include the precise location of S1 and S2, the mode of
lateral translocation of AChRs, the origin and nature of S1 and S2,
and how S1 and S2 induce stabilization of AChRs. Finally, it
would be very interesting to know, if additional signals would be
able to further prolong receptor lifetime, or if a t1/2 of about 13
days is just the maximum obtainable.
Table 2. AChRs exhibit three different half-lives, depending on the state of innervation.
compartment size
%
rate constant
(d21)
half-life
(d) mean lifetime (d)
innervated
fast compartment
1362 0.63060.191 1.160.3 1.660.5
innervated
slow compartment
8762 0.05360.002 13.160.4 18.960.6
acutely denervated
fast compartment
562 0.63060.417 1.160.7 1.661.1
acutely denervated
slow compartment
9562 0.08660.002 8.160.2 11.660.2
long-term denervated
fast compartment
5164 0.63060.070 1.160.1 1.660.1
long-term denervated
slow compartment
4964 0.08660.007 8.160.6 11.660.6
TA muscles of anaesthetized mice were injected with 125I-BGT on day zero and then 125I emission from injected hindlimbs was measured over 25 days. Regressions from
data sets normalized to day 2 after pulse labeling were calculated using two-exponential terms and t1/2 values of 1.1 days (fast compartment), 8.1 days (intermediate
compartment) and 13.1 days (slow compartment). The table shows compartment sizes, rate constants, half-lives, and mean receptor lifetimes, all6 SD (n-values: control
n = 10, acutely denervated n= 5, long-term denervated n= 4).
doi:10.1371/journal.pone.0020524.t002
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Materials and Methods
Ethics statement
Use and care of animals was as approved by German authorities
(Tierschutzkommission of the Regierungspra¨sidium Karlsruhe,
license G-22/07) according to national law (TierSchG 17).
Chemicals
Lyophilized radioactive a-BGT[125I]Tyr54 (125I-BGT) with a
specific activity of 81.4 TBq/mmol (2200 Ci/mmol) was from
Perking Elmer. Injection-ready solution was prepared by adding
sterile aqua dest. according to manufacturer description. Decay of
125I is mainly characterized by electron capture (93%). The whole
spectrum is showing X-ray-, electron- and gamma peaks. BGT
coupled to AlexaFluors 555 (BGT-AF555) and 647 (BGT-AF647)
were from Invitrogen.
Animals, anaesthesia, denervation and 125I-BGT injection
For experiments, 20–32 weeks old male wild-type mice were
bred in our rodent facility. Denervation was performed as
described previously [10] and labeling of TA muscles was done
under anesthesia with a combination of Xylazin (Bayer) and
Zoletil (Laboratories Virbac) by intraperitoneal injection. During
measurements of 125I-BGT animals were anaesthetized with an
Isoflurane – air mixture (0.6–1.5%) administered by a tube for
about 10 minutes. For hindlimb denervation 5 mm of the sciatic
nerve were removed. Success of denervation was checked in
sacrificed mice at the end of each experiment. Right hindlimbs of
each mouse served as innervated control. For labeling muscle
AChRs 10 ml of 125I-BGT, containing 0.46 MBq (2,5 mCi) 125I,
were injected into dissected TA muscles in both hindlimbs. In
long-term denervation experiments 125I-BGT was injected five
days after denervation. A single dose of 125I-BGT averaged to
0.01 mg or 1 pmol. LD50 of a-BGT is about 3.5 mg per 100 g body
weight [28].
Measurements of 125I emission in vivo
For in vivo detection of emitted X-rays from 125I-BGT-labeled
TA muscles a portable Germanium semiconductor counter
(Model GX3018, Canberra, Belgium) was used. Anaesthetized
mice were mounted onto a lead support and both hindlimbs were
fixed in a defined position for detection. The lead support of
20 mm thickness efficiently blocked radiation cross talk between
both legs during measurement. To further narrow down emission
detection to the hindlimbs, radiation deriving from the whole
mouse body was blocked by a lead shield with a circular
fenestration for the TA muscle (Fig. 1A–B). Duration of each
measurement for a single leg was 300 s (statistical counting error
,2%). Stability of the detector system and the chosen geometry
was checked by repeated measurements of an aliquot of 125I-BGT
(10 ml) in a test tube. Data from the detector were analyzed using
an attached multi channel analyzer (InSpector 2000 DSP Portable
Spectroscopy Workstation, Canberra). In all experiments we used
the X-ray peak area in the range between 25.5 to 28.5 keV (peaks
at 27.2 keV and 27.5 keV). All experiments were performed under
an extractor hood.
Measurements of 125I emission ex vivo and of litter
samples
For an approximate assessment of radioactivity distribution
during the experiments, single mice were kept in separate cages.
Residual radioactivity in the litter and the mouse was measured at
Figure 4. Two nerve-activity-dependent signals mediate full metabolic stabilization of AChRs. A: Scheme summarizing the findings of
the 125I-BGT approach. Upon delivery of AChRs to the synapse, the presence of the nerve-activity-dependent signal, S1, triggers the prolongation of
the receptor half-life from ,1 to ,8 days. When not stabilized receptors are degraded. During or at the end of the first week another nerve-activity-
dependent signal, S2, is needed to extend the receptor half-life to now,13 days. B: Enlargements from Fig. 3E indicate the preferential incorporation
of newly formed AChRs at the periphery of NMJs. Pictures show NMJs of innervated (left), acutely denervated (middle) or long-term denervated
(right) muscles. ‘Old receptors’ are shown in green, ‘new receptors’ in red. Note, that with increasing time of denervation-induced absence of AChR
stabilization the domain where ‘new receptors’ prevail progressively expands from the periphery of NMJs towards the center. Scale bar, 10 mm. C:
Transmission electron micrograph through a NMJ. The picture shows the cross-section of one arbor (exemplified by the dotted rectangle in B, left
panel). The upper left half shows the presynaptic terminal, the lower right half shows the muscular, post-synaptic apparatus. 1, primary synaptic cleft;
2, secondary synaptic cleft; G, Golgi apparatus; M, mitochondria; N, subsynaptic nucleus; SV, synaptic vesicles. Scale bar, 1 mm. The region of the Golgi
apparatus (for better visibility contrast-corrected) is enlarged in the insert. D: Scheme illustrating the hypothesized lateral movement of AChRs within
the NMJ and the presumptive spatial localization of S1 and S2. Red rectangles, AChRs; spheres, exocytic (left) and recycling vesicles (middle and right).
doi:10.1371/journal.pone.0020524.g004
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the end of the experiment using stationary Germanium semicon-
ductor counters in an ILAC (www.ilac.org) on ISO 17025:2005
accredited lab.
Data analysis
Experimental data of AChR degradation were assessed first
visually and subsequently numerically using SigmaPlot (Systat
software, Inc.). Exponential release of 125I-BGT was analyzed by
regression equations with two exponential terms (using four
parameters) and least square fits using the following term:
Ft~A0e
-b:tzC0e
-d:t ð1Þ
To analyze the receptor bound kinetics data were typically
normalized to day two after pulse labeling as described elsewhere
[15], when the unbound 125I-BGT was evacuated completely. All
error bars represent standard error of the mean. Significance
analysis of degradation rates used Student’s t-test. For character-
ization of exponentially first order processes several parameters
were derived:
Half{life, t1=2 dð Þ t1=2~ ln 2
k
ð2Þ
elimination rate constant, k (d{1) k~
ln 2
t1=2
ð3Þ
mean lifetime, t dð Þ t~ 1
k
ð4Þ
In vivo imaging and data analysis
Microscopic determination of AChR turnover (Fig. 3E) and
automated data extraction and analysis (Fig. 3F) were as described
[10]. Briefly, 3D stacks at 5126512 pixel resolution were taken of
BGT-AF647 (‘old receptors’) and of BGT-AF555 signals (‘new
receptors’) using a 63x objective and confocal in vivo imaging.
Then, synapses were automatically identified and segmented in 3D
using a custom-made algorithm [10]. For each pixel in the
segmented NMJs the signal intensity values for AF555 and AF647
were extracted. Then, the fraction of pixels per NMJ where the
AF555 signal intensity was higher than that of AF647 was
calculated.
Electron microscopy
Mice were killed by cervical dislocation, TA muscles were
removed and fixed overnight at 4uC in 2% paraformaldehyde/
1.25% glutaraldehyde in 0.1 M Pipes pH 7.0 containing 0.1%
NaN3. Postfixation for 1 h on ice in 0.5% OsOs4/ 0.8%
K3[Fe(CN)6] in 0.1 M Pipes was followed by block-staining
overnight at 4uC in 2% uranylacetate/25% ethanol. Samples
were dehydrated in ethanol and infiltrated via propylenoxide with
Epon according to standard protocols.
Supporting Information
Figure S1 Schematic of the detector setup. All values
indicate distances in millimeters. A: Top view of the detector
setup. B: Side view of the detector setup. C: Side view of the lead
block used to mount the anesthetized animal. The red ring
indicates the position, where hindlimb muscles were fixed.
(TIF)
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